Gilead describes Veklury as the “first and only approved treatment for Covid-19” in the United States. There, the sick President Donald Trump, among others, was administered the drug. He ended up in hospital this month after contracting the corona virus. Remdesivir was originally developed to fight other viruses.
In Europe, the medicines agency gave EMA a conditional market authorization for Veklury in early July. The European Commission, the EU’s executive committee, has purchased hundreds of thousands of doses of the drug from Gilead in recent months. This was done in the context of a joint purchase procedure on behalf of dozens of European countries, including the Netherlands.
The most important financial news every morning.
Invalid email address. Please fill in again.
*The article has been translated based on the content of Source link by https://www.telegraaf.nl/financieel/1719006052/toezichthouder-vs-keurt-coronamedicijn-remdesivir-goed
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!
These were the details of the news US regulator approves ‘corona drug’ remdesivir | Financial for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.